Barrett’s Esophagus Test Identifies High-Risk Patients Missed by Standard Pathology
A study of 85 patients shows the TissueCypher test detected 15% with elevated cancer progression risk despite a non-dysplastic diagnosis.
Category: Uncategorized
Uncategorized
Latest
Uncategorized
Latest
Color Health Partners with CDC to Increase Access to COVID Testing
Color Health is providing free COVID testing through the CDC's Increasing Community Access to Testing program.
Uncategorized
Latest
Ortho Clinical Diagnostics, Thermo Fisher Scientific Partner on QC Solutions
Ortho Clinical Diagnostics has a distribution agreement with Thermo Fisher Scientific to provide and support MAS Quality Controls and LabLink xL Quality Assurance Software through Ortho's Vitros QC Solutions to Vitros System customers worldwide.
Clinical Chemistry
Latest
2026 Clinical Chemistry Analyzers Comparison Guide
Compare clinical chemistry analyzers from leading manufacturers with side-by-side specifications to help laboratories of all sizes evaluate throughput, workflow, assay menus, and more.
Flow Cytometry
Latest
ARUP Laboratories Launches Spectral Flow Cytometry Test for Multiple Myeloma Monitoring
The assay is designed to detect minimal residual disease with greater sensitivity than conventional flow cytometry.
Mass Spectrometry
Latest
ADLM 2026 Draws 17,000 Attendees to Explore Advances in Clinical Laboratory Medicine
ADLM 2026 drew nearly 17,000 professionals to Anaheim, where experts discussed advances in space diagnostics, mass spectrometry, and chronic disease management, and Kompass Diagnostics won the Disruptive Technology Award for its IDA platform.
Immunoassay
Latest
Alzheimer’s Blood Tests Found Effective for Patients with Down Syndrome
USC researchers report that two blood tests, Lumipulse G p-tau217/β-Amyloid 1-42 and PrecivityAD2, can accurately detect Alzheimer’s pathology in patients with Down syndrome.
Molecular Diagnostics
Latest
Co-Diagnostics Submits FDA Notification for Upper Respiratory Multiplex Test
Co-Diagnostics has submitted a Dual 510(k) and CLIA waiver application to the FDA for its PCR-based flu and RSV test, aiming to enable point-of-care use on the Co-Dx PCR Pro instrument.
Point-of-Care
Latest
Roche Receives FDA Clearance for Point-of-Care Bordetella Test
The cobas liat system delivers PCR results in 15 minutes, detecting and differentiating between three Bordetella pathogens including whooping cough.